Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

XFORX4 Pharmaceuticals, Inc

Nasdaq · CIK 0001501697
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts398

Identity from submissions API

NameX4 Pharmaceuticals, Inc
CIK0001501697
TickersXFOR
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN273181608
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone857-529-8300
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Arsanis, Inc. (2010-09-24T04:00:00.000Z → 2019-03-13T04:00:00.000Z)
Business address
61 NORTH BEACON STREET
4TH FLOOR
BOSTON
MA
02134
MA
Mailing address
61 NORTH BEACON STREET
4TH FLOOR
BOSTON
MA
02134
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

821 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000100 005-90199 261563206 34 18131
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005081 005-90199 261555818 34 14332
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127412 005-90199 261554945 34 19544
2026-11-04 10-Q 10-Q 0001501697-26-000089 001-38295 261522121 34 8494798 1 1
2026-10-29 8-K 8-K 8.01,9.01 0001501697-26-000084 001-38295 261498137 34 4479678 1 1
2026-10-19 4 FORM 4 0001339498-26-000005 5243
2026-10-08 8-K 8-K 1.01,1.02,2.03,3.02,7.01,9.01 0001501697-26-000081 001-38295 261450589 34 175403 1 1
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002326 005-90199 261446103 34 11601
2026-10-05 4 FORM 4 0001501697-26-000078 5659
2026-10-01 144 xsl144X01/primary_doc.xml 0001276750-26-000008 001-38295 261433100 33 5312
2026-09-21 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000071 005-90199 261395051 34 35222
2026-09-09 8-K 8-K 8.01,9.01 0001501697-26-000076 001-38295 261366019 34 2844241 1 1
2026-09-08 8-K 8-K 8.01,9.01 0001501697-26-000072 001-38295 261363365 34 158584 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352651 005-90199 261283770 34 11495
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003487 005-90199 261276439 34 14317
2026-08-13 4 FORM 4 0001501697-26-000070 5627
2026-08-13 4 FORM 4 0001501697-26-000069 5660
2026-08-13 144 xsl144X01/primary_doc.xml 0002081729-26-000004 001-38295 261272973 33 5290
2026-08-13 144 xsl144X01/primary_doc.xml 0001339498-26-000003 001-38295 261272963 33 5317
2026-08-06 10-Q 10-Q 0001501697-26-000068 001-38295 261249010 34 7057708 1 1
2026-07-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003133 005-90199 261221124 34 10903
2026-07-01 4 FORM 4 0001501697-26-000065 5658
2026-07-01 4 FORM 4 0001501697-26-000064 5594
2026-07-01 3 FORM 3 0001501697-26-000063 10388
2026-07-01 8-K 8-K 5.02,7.01,9.01 0001501697-26-000060 001-38295 261145271 34 175160 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226568 005-90199 26986554 34 11494
2026-05-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001669 333-295597 26990657 33 1864
2026-05-13 8-K/A 8-K/A 5.02,5.07,9.01 0001501697-26-000051 001-38295 26974345 34 311468 1 1
2026-05-13 4 FORM 4 0001501697-26-000049 5659
2026-05-12 144 xsl144X01/primary_doc.xml 0001276750-26-000004 001-38295 26970215 33 4777
2026-05-12 8-K 8-K 5.02,5.07 0001501697-26-000047 001-38295 26968943 34 309417 1 1
2026-05-12 CORRESP filename1.htm 0001501697-26-000046 6861
2026-05-11 UPLOAD filename1.pdf 0000000000-26-004784 333-295597 149726
2026-05-06 S-3 S-3 0001501697-26-000043 333-295597 26948409 33 1539792 1 1
2026-05-06 10-Q 10-Q 0001501697-26-000040 001-38295 26945757 34 6566153 1 1
2026-03-20 ARS ARS 0001501697-26-000033 001-38295 26776351 34 48062645
2026-03-20 DEFA14A DEFA14A 0001501697-26-000032 001-38295 26776327 34 433219
2026-03-20 DEF 14A DEF 14A 0001501697-26-000031 001-38295 26776324 34 3699751 1 1
2026-03-18 S-8 S-8 0001501697-26-000021 333-294391 26764387 33 242720 1 1
2026-03-17 10-K 10-K 0001501697-26-000018 001-38295 26759037 34 11434031 1 1
2026-03-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-26-000094 005-90199 26731356 34 13700
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000476 005-90199 26642224 34 24828
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-007144 005-90199 26642172 34 11753
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054779 005-90199 26642118 34 173856
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016241 005-90199 26639888 34 13198
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015354 005-90199 26634461 34 11014
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-26-000068 005-90199 26625447 34 12032
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000584 005-90199 26602218 34 12123
2026-01-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000246 005-90199 26535560 34 12811
2026-01-07 4 FORM 4 0001501697-26-000009 283428
2026-01-05 4 FORM 4 0001501697-26-000007 284214
2026-01-05 4 FORM 4 0001501697-26-000006 283336
2026-01-05 4 FORM 4 0001501697-26-000005 283698
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112658 005-90199 251487459 34 10968
2025-11-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002923 005-90199 251461149 34 11532
2025-11-05 10-Q 10-Q 0001501697-25-000043 001-38295 251451922 34 8006540 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001501697-25-000041 001-38295 251451884 34 248227 1 1
2025-11-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-262560 005-90199 251444166 34 367483
2025-10-31 4 FORM 4 0001339498-25-000004 5803
2025-10-31 4 FORM 4 0002081729-25-000003 5770
2025-10-31 4 FORM 4 0001276750-25-000004 5785
2025-10-29 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-25-000747 005-90199 251431423 34 92183
2025-10-27 4 FORM 4 0001501697-25-000035 4852
2025-10-27 8-K 8-K 1.01,9.01 0001501697-25-000032 001-38295 251417169 34 726088 1 1
2025-10-24 424B5 424B5 0001501697-25-000031 333-273961 251416897 33 491829
2025-10-23 424B5 424B5 0001501697-25-000027 333-273961 251413192 33 488125
2025-10-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004474 005-90199 251405450 34 17931
2025-10-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-096741 005-90199 251375051 34 17639
2025-09-18 424B3 424B3 0001501697-25-000024 333-290158 251323663 33 203548
2025-09-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002994 333-290158 251321691 33 1865
2025-09-17 8-K 8-K 2.05,5.02,7.01,9.01 0001501697-25-000021 001-38295 251318774 34 211694 1 1
2025-09-15 CORRESP filename1.htm 0001501697-25-000019 10467
2025-09-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-203640 005-90199 251314687 34 149728
2025-09-15 UPLOAD filename1.pdf 0000000000-25-009968 333-290158 40211
2025-09-10 S-3 S-3 0001501697-25-000017 333-290158 251306077 33 345866
2025-09-10 S-8 S-8 0001501697-25-000016 333-290155 251306024 33 88784
2025-08-25 D xslFormDX01/primary_doc.xml 06b 0001470831-25-000145 021-555727 251251391 33 14812
2025-08-25 8-K 8-K 5.02 0001501697-25-000008 001-38295 251247964 34 147708 1 1
2025-08-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-002347 005-90199 251237900 34 40262
2025-08-19 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003668 005-90199 251231711 34 12016
2025-08-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-024646 005-90199 251228603 34 26007
2025-08-18 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-079821 005-90199 251228236 34 34173
2025-08-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-25-000643 005-90199 251225418 34 94509
2025-08-14 4 FORM 4 0001628280-25-040444 9405
2025-08-14 3 FORM 3 0001628280-25-040443 9982
2025-08-14 3 FORM 3 0001628280-25-040442 27436
2025-08-14 4 FORM 4 0001628280-25-040441 9436
2025-08-14 4 FORM 4 0001628280-25-040440 9680
2025-08-14 3 FORM 3 0001628280-25-040439 10313
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000947871-25-000777 005-90199 251221439 34 7594
2025-08-13 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-108341 005-90199 251213873 34 157021
2025-08-13 8-K 8-K 1.01,3.02,8.01,9.01 0001501697-25-000006 001-38295 251209070 34 726419 1 1
2025-08-12 8-K 8-K 1.01,3.02,5.02,8.01,9.01 0001628280-25-039770 001-38295 251204165 34 917288 1 1
2025-08-08 10-Q 10-Q 0001628280-25-039327 001-38295 251199319 34 8532804 1 1
2025-07-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003306 005-90199 251133252 34 11129
2025-07-03 4 FORM 4 0001628280-25-034233 5544
2025-06-23 8-K 8-K 1.01,9.01 0001628280-25-032627 001-38295 251065351 34 736545 1 1
2025-06-23 424B5 424B5 0001628280-25-032526 333-273961 251063014 33 435419
2025-06-11 8-K 8-K 5.07 0001628280-25-030743 001-38295 251040217 34 161721 1 1
2025-06-10 4 FORM 4 0001628280-25-030504 5126
2025-06-10 4 FORM 4 0001628280-25-030503 5107
2025-06-10 4 FORM 4 0001628280-25-030502 5123
2025-06-10 4 FORM 4 0001628280-25-030500 5114
2025-06-10 4 FORM 4 0001628280-25-030492 5072
2025-06-10 4 FORM 4 0001628280-25-030489 5110
2025-06-03 3 FORM 3 0001628280-25-029175 324707
2025-06-03 4/A FORM 4/A 0001628280-25-029113 5532
2025-05-20 4 FORM 4 0001628280-25-026864 4911
2025-05-01 10-Q 10-Q 0001628280-25-021358 001-38295 25899905 34 8017840 1 1
2025-05-01 8-K 8-K 2.02,7.01 0001628280-25-021304 001-38295 25899188 34 5247339 1 1
2025-04-25 DEF 14A DEF 14A 0001628280-25-019926 001-38295 25874857 34 2571528 1 1
2025-04-25 DEFA14A DEFA14A 0001628280-25-019934 001-38295 25873980 34 279507
2025-04-24 8-K 8-K 5.03,8.01,9.01 0001628280-25-019507 001-38295 25863839 34 220681 1 1
2025-04-18 8-K 8-K 5.07 0001628280-25-018389 001-38295 25850593 34 160543 1 1
2025-03-26 S-8 S-8 0001628280-25-014806 333-286107 25769984 33 143161
2025-03-26 10-K 10-K 0001628280-25-014805 001-38295 25769602 34 11875709 1 1
2025-03-25 8-K 8-K 2.02,9.01 0001628280-25-014601 001-38295 25765886 34 288888 1 1
2025-03-24 DEF 14A DEF 14A 0001628280-25-014535 001-38295 25764717 34 501655
2025-03-14 PRE 14A PRE 14A 0001628280-25-012815 001-38295 25740028 34 496342
2025-03-03 8-K 8-K 8.01 0001628280-25-009490 001-38295 25699228 34 158751 1 1
2025-02-14 4 FORM 4 0001628280-25-005704 5329
2025-02-14 4 FORM 4 0001628280-25-005702 5310
2025-02-14 4 FORM 4 0001628280-25-005700 5306
2025-02-14 4 FORM 4 0001628280-25-005698 8371
2025-02-14 4 FORM 4 0001628280-25-005696 5267
2025-02-06 8-K 8-K 2.05,7.01,9.01 0001628280-25-004254 001-38295 25597379 34 205599 1 1
2025-01-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000265 005-90199 25576418 34 6369
2025-01-27 4 FORM 4 0001628280-25-002709 7206
2025-01-27 4 FORM 4 0001628280-25-002708 7202
2025-01-27 4 FORM 4 0001628280-25-002707 7189
2025-01-27 4 FORM 4 0001628280-25-002706 7166
2025-01-27 4 FORM 4 0001628280-25-002705 7227
2025-01-24 144 xsl144X01/primary_doc.xml 0001973141-25-000044 001-38295 25554502 33 5159
2025-01-24 144 xsl144X01/primary_doc.xml 0001973141-25-000043 001-38295 25554494 33 4488
2025-01-24 144 xsl144X01/primary_doc.xml 0001973141-25-000041 001-38295 25554458 33 4488
2025-01-24 144 xsl144X01/primary_doc.xml 0001973141-25-000040 001-38295 25554447 33 4496
2025-01-24 144 xsl144X01/primary_doc.xml 0001973141-25-000038 001-38295 25554318 33 4568
2025-01-24 144 xsl144X01/primary_doc.xml 0001973141-25-000037 001-38295 25554282 33 4511
2025-01-16 S-8 S-8 0001628280-25-001740 333-284320 25536167 33 115891
2025-01-13 8-K 8-K 1.01,7.01,9.01 0001628280-25-001239 001-38295 25524842 34 5575434 1 1
2025-01-07 UPLOAD filename1.pdf 0000000000-25-000138 001-38295 39806
2024-12-23 CORRESP filename1.htm 0001628280-24-052321 321721
2024-12-13 UPLOAD filename1.pdf 0000000000-24-013733 001-38295 43323
2024-11-19 4 FORM 4 0001628280-24-048467 5384
2024-11-15 144 xsl144X01/primary_doc.xml 0001973141-24-000559 001-38295 241467973 33 6310
2024-11-13 10-Q 10-Q 0001628280-24-047445 001-38295 241451451 34 7474993 1 1
2024-11-13 8-K 8-K 7.01,8.01,9.01 0001628280-24-047433 001-38295 241451286 34 4407157 1 1
2024-11-13 8-K 8-K 2.02,9.01 0001628280-24-047406 001-38295 241451014 34 290610 1 1
2024-11-12 SC 13G/A UnitedStates_13G__X4Pharmace.txt 0000932471-24-001295 005-90199 241450333 34 6674
2024-11-08 SC 13G us98420x1037_110824.txt 0002012383-24-003456 005-90199 241439584 34 13728
2024-11-04 SC 13G/A UnitedStates_13G__X4Pharmace.txt 0000932471-24-000783 005-90199 241422620 34 5724
2024-10-22 SC 13G us98420x1037_102224.txt 0002012383-24-001574 005-90199 241387314 34 13714
2024-10-16 4 FORM 4 0001628280-24-042941 5387
2024-10-15 144 xsl144X01/primary_doc.xml 0001973141-24-000500 001-38295 241371911 33 6196
2024-10-08 4 FORM 4 0001628280-24-042545 7040
2024-10-08 4 FORM 4 0001628280-24-042544 7018
2024-10-08 4 FORM 4 0001628280-24-042543 7039
2024-10-08 4 FORM 4 0001628280-24-042542 6997
2024-10-08 4 FORM 4 0001628280-24-042541 7044
2024-10-07 144 xsl144X01/primary_doc.xml 0001973141-24-000493 001-38295 241358008 33 5109
2024-10-07 144 xsl144X01/primary_doc.xml 0001973141-24-000492 001-38295 241358003 33 4491
2024-10-07 144 xsl144X01/primary_doc.xml 0001973141-24-000490 001-38295 241357941 33 4539
2024-10-07 144 xsl144X01/primary_doc.xml 0001973141-24-000489 001-38295 241357864 33 4511
2024-10-07 144 xsl144X01/primary_doc.xml 0001973141-24-000488 001-38295 241357846 33 4496
2024-10-04 S-8 S-8 0001628280-24-042323 333-282513 241355475 33 103520
2024-09-11 4 FORM 4 0001628280-24-040128 5450
2024-09-09 144 xsl144X01/primary_doc.xml 0001973141-24-000445 001-38295 241287309 33 4477
2024-08-16 8-K 8-K 3.01 0001628280-24-037546 001-38295 241216648 34 158958 1 1
2024-08-09 8-K 8-K 7.01 0001628280-24-036495 001-38295 241193199 34 155651 1 1
2024-08-08 10-Q 10-Q 0001628280-24-036127 001-38295 241188310 34 21572966 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001628280-24-035848 001-38295 241185899 34 290990 1 1
2024-07-19 8-K 8-K 7.01 0001628280-24-032266 001-38295 241126125 34 155624 1 1
2024-06-27 8-K 8-K 7.01,8.01,9.01 0001628280-24-030243 001-38295 241075400 34 4654106 1 1
2024-06-11 8-K 8-K 5.07 0001628280-24-027680 001-38295 241035919 34 172427 1 1
2024-06-11 4 FORM 4 0001628280-24-027678 5116
2024-06-11 4 FORM 4 0001628280-24-027677 5122
2024-06-11 4 FORM 4 0001628280-24-027676 5081
2024-06-11 4 FORM 4 0001628280-24-027675 5136
2024-06-11 4 FORM 4 0001628280-24-027674 5132
2024-06-11 4 FORM 4 0001628280-24-027673 5124
2024-06-11 4 FORM 4 0001628280-24-027672 5186
2024-06-11 4 FORM 4 0001628280-24-027671 5120
2024-05-22 8-K 8-K 7.01,9.01 0001628280-24-024633 001-38295 24971676 34 4409141 1 1
2024-05-09 8-K 8-K 1.01,2.01,5.02,7.01,8.01,9.01 0001628280-24-021937 001-38295 24928451 34 199827 1 1
2024-05-07 10-Q 10-Q 0001628280-24-021120 001-38295 24922370 34 5910883 1 1
2024-05-07 8-K 8-K 2.02,9.01 0001628280-24-020827 001-38295 24919485 34 244716 1 1
2024-04-29 ARS ARS 0001628280-24-019063 001-38295 24892234 34 46715218
2024-04-29 DEFA14A DEFA14A 0001628280-24-019058 001-38295 24892176 34 274541
2024-04-29 DEF 14A DEF 14A 0001628280-24-019056 001-38295 24892153 34 1398967
2024-04-29 8-K 8-K 7.01,8.01,9.01 0001628280-24-018793 001-38295 24886748 34 3938092 1 1
2024-04-29 8-K 8-K 7.01,8.01,9.01 0001628280-24-018773 001-38295 24886456 34 233494 1 1
2024-04-05 8-K 8-K 8.01 0001628280-24-015059 001-38295 24826907 34 155844 1 1
2024-04-01 8-K 8-K 7.01 0001628280-24-013896 001-38295 24805929 34 155666 1 1
2024-03-21 10-K 10-K 0001628280-24-012578 001-38295 24772234 34 9912956 1 1
2024-03-21 8-K 8-K 2.02 0001628280-24-012372 001-38295 24769471 34 276759 1 1
2024-03-11 4 FORM 4 0001628280-24-010281 5497
2024-03-11 4 FORM 4 0001628280-24-010280 5486
2024-03-11 4 FORM 4 0001628280-24-010279 5306
2024-03-11 4 FORM 4 0001628280-24-010278 5445
2024-03-11 144 xsl144X01/primary_doc.xml 0001973141-24-000169 001-38295 24738243 33 5123
2024-03-11 144 xsl144X01/primary_doc.xml 0001973141-24-000168 001-38295 24738077 33 5116
2024-03-11 144 xsl144X01/primary_doc.xml 0001973141-24-000167 001-38295 24737949 33 5115
2024-03-11 144 xsl144X01/primary_doc.xml 0001973141-24-000166 001-38295 24737942 33 5160
2024-02-28 4/A FORM 4/A 0001628280-24-007711 6199
2024-02-16 4 FORM 4 0001628280-24-005385 5737
2024-02-16 4 FORM 4 0001628280-24-005384 5718
2024-02-16 4 FORM 4 0001628280-24-005383 5674
2024-02-16 4 FORM 4 0001628280-24-005382 5715
2024-02-16 4 FORM 4 0001628280-24-005380 5698
2024-02-16 4 FORM 4 0001628280-24-005379 5721
2024-02-14 SC 13G/A AMENDMENT NO. 4 0000947871-24-000161 005-90199 24641506 34 69832
2024-02-14 SC 13G p24-0888sc13g.htm 0000902664-24-001745 005-90199 24639599 34 117976
2024-02-14 SC 13G/A SCHEDULE 13G/A 0001104659-24-023820 005-90199 24639216 34 116672
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-034104 005-90199 24630915 34 148179
2024-02-12 4 FORM 4 0001628280-24-004288 5443
2024-02-12 4 FORM 4 0001628280-24-004287 5490
2024-02-12 4 FORM 4 0001628280-24-004266 5560
2024-02-12 4 FORM 4 0001628280-24-004263 5382
2024-02-12 144 xsl144X01/primary_doc.xml 0001973141-24-000107 001-38295 24620400 33 4489
2024-02-12 144 xsl144X01/primary_doc.xml 0001973141-24-000106 001-38295 24620389 33 4494
2024-02-12 144 xsl144X01/primary_doc.xml 0001973141-24-000103 001-38295 24619908 33 4476
2024-02-12 144 xsl144X01/primary_doc.xml 0001973141-24-000098 001-38295 24619778 33 4531
2024-02-07 SC 13G/A us98420x1037_020724.txt 0001086364-24-006819 005-90199 24605683 34 12551
2024-01-31 SC 13G us98420x1037_013124.txt 0001086364-24-006042 005-90199 24582142 34 13416
2024-01-25 S-8 S-8 0001628280-24-002243 333-276691 24562474 33 98933
2024-01-16 SC 13G/A XFOR_SC13GA1.htm 0001273087-24-000017 005-90199 24535389 34 81817
2024-01-08 8-K 8-K 7.01 0001628280-24-000843 001-38295 24520153 34 158727 1 1
2024-01-08 SC 13G/A X4 PHARMACEUTICALS, INC. 0000902664-24-000073 005-90199 24518808 34 78090
2023-11-27 8-K 8-K 7.01 0001628280-23-040050 001-38295 231441101 34 158681 1 1
2023-11-14 8-K 8-K 3.01 0001628280-23-038936 001-38295 231406219 34 162021 1 1
2023-11-09 10-Q 10-Q 0001628280-23-038334 001-38295 231393715 34 7282635 1 1
2023-11-09 8-K 8-K 2.02 0001628280-23-038053 001-38295 231390168 34 284842 1 1
2023-11-03 4 FORM 4 0001628280-23-036796 7461
2023-11-03 4 FORM 4 0001628280-23-036758 5317
2023-11-03 4 FORM 4 0001628280-23-036757 5452
2023-11-03 4 FORM 4 0001628280-23-036756 5476
2023-11-03 4 FORM 4 0001628280-23-036755 5499
2023-11-03 144 xsl144X01/primary_doc.xml 0001973141-23-000278 001-38295 231376232 33 5044
2023-11-02 4 FORM 4 0001628280-23-036471 4961
2023-11-02 4 FORM 4 0001628280-23-036466 4939
2023-11-02 4 FORM 4 0001628280-23-036463 4964
2023-11-02 4 FORM 4 0001628280-23-036462 4956
2023-11-02 4 FORM 4 0001628280-23-036459 4917
2023-11-01 144 xsl144X01/primary_doc.xml 0001973141-23-000269 001-38295 231368168 33 4453
2023-11-01 144 xsl144X01/primary_doc.xml 0001973141-23-000268 001-38295 231368146 33 5036
2023-11-01 144 xsl144X01/primary_doc.xml 0001973141-23-000266 001-38295 231368109 33 4449
2023-11-01 144 xsl144X01/primary_doc.xml 0001973141-23-000265 001-38295 231368099 33 4419
2023-11-01 144 xsl144X01/primary_doc.xml 0001973141-23-000264 001-38295 231368076 33 4468
2023-10-31 8-K 8-K 8.01 0001628280-23-035729 001-38295 231364860 34 202607 1 1
2023-10-18 4 FORM 4 0001628280-23-034579 4842
2023-10-18 3 FORM 3 0001628280-23-034577 355618
2023-10-18 8-K 8-K 5.02,7.01 0001628280-23-034547 001-38295 231330967 34 200898 1 1
2023-09-12 4 FORM 4 0001628280-23-032065 5346
2023-09-08 144 xsl144X01/primary_doc.xml 0001973141-23-000210 001-38295 231245248 33 6285
2023-09-05 8-K 8-K 8.01 0001628280-23-031405 001-38295 231236683 34 218862 1 1
2023-09-05 4 FORM 4 0001628280-23-031389 5623
2023-08-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-08-24 16:00:00 9999999995-23-002489 333-273961 231203719 33 1823
2023-08-22 4 FORM 4 0001628280-23-030224 5171
2023-08-22 CORRESP filename1.htm 0001628280-23-030216 10059
2023-08-21 UPLOAD filename1.pdf 0000000000-23-009115 40371
2023-08-16 3 FORM 3 SUBMISSION 0001209191-23-046012 6851
2023-08-14 S-3 S-3 0001628280-23-029155 333-273961 231165841 33 816393
2023-08-14 S-8 S-8 0001628280-23-029154 333-273960 231165839 33 262307
2023-08-11 4 FORM 4 0001628280-23-029148 7002
2023-08-10 10-Q 10-Q 0001628280-23-028897 001-38295 231160120 34 7740328 1 1
2023-08-10 8-K 8-K 2.02 0001628280-23-028730 001-38295 231157101 34 296149 1 1
2023-08-03 8-K 8-K 1.01,2.03,7.01 0001628280-23-027303 001-38295 231140829 34 214348 1 1
2023-07-05 4 FORM 4 0001628280-23-024229 5343
2023-07-05 4 FORM 4 0001628280-23-024228 5334
2023-06-30 144 xsl144X01/primary_doc.xml 0001973141-23-000116 001-38295 231061444 33 5615
2023-06-30 144 xsl144X01/primary_doc.xml 0001973141-23-000115 001-38295 231061377 33 5721
2023-06-26 4 FORM 4 0001628280-23-023445 5348
2023-06-26 4 FORM 4 0001628280-23-023443 5334
2023-06-26 4 FORM 4 0001628280-23-023440 5384
2023-06-23 144 xsl144X01/primary_doc.xml 0001973141-23-000106 001-38295 231037505 33 4988
2023-06-23 144 xsl144X01/primary_doc.xml 0001973141-23-000105 001-38295 231037449 33 5662
2023-06-23 144 xsl144X01/primary_doc.xml 0001973141-23-000104 001-38295 231037416 33 5093
2023-06-21 424B3 424B3 0001193125-23-170302 333-272551 231026627 33 240175
2023-06-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-06-20 16:00:00 9999999995-23-001801 333-272551 231027343 33 1823
2023-06-16 4 FORM 4 0001628280-23-022480 5343
2023-06-16 4 FORM 4 0001628280-23-022473 5318
2023-06-16 4 FORM 4 0001628280-23-022469 5384
2023-06-16 CORRESP filename1.htm 0001628280-23-022467 11684
2023-06-16 SC 13G XFOR_SC13G.htm 0001273087-23-000117 005-90199 231020931 34 81719
2023-06-16 UPLOAD filename1.pdf 0000000000-23-006515 40227
2023-06-15 8-K 8-K 5.07 0001628280-23-022266 001-38295 231017948 34 204645 1 1
2023-06-15 144 xsl144X01/primary_doc.xml 0001973141-23-000092 001-38295 231017920 33 5148
2023-06-15 144 xsl144X01/primary_doc.xml 0001973141-23-000090 001-38295 231017245 33 4361
2023-06-15 144 xsl144X01/primary_doc.xml 0001973141-23-000089 001-38295 231017217 33 4447
2023-06-14 4 FORM 4 0001628280-23-022099 5043
2023-06-14 4 FORM 4 0001628280-23-022096 5052
2023-06-14 4 FORM 4 0001628280-23-022093 5001
2023-06-14 4 FORM 4 0001628280-23-022091 5039
2023-06-14 4 FORM 4 0001628280-23-022090 5036
2023-06-14 4 FORM 4 0001628280-23-022084 5106
2023-06-09 S-3 S-3 0001628280-23-021708 333-272551 231005389 33 360647
2023-06-01 D xslFormDX01/primary_doc.xml 06b 0001231919-23-000037 021-483142 23985291 33 19899
2023-06-01 8-K 8-K 7.01 0001628280-23-020502 001-38295 23984861 34 177773 1 1
2023-05-31 4 FORM 4 0001628280-23-020355 5433
2023-05-31 144 xsl144X01/primary_doc.xml 0001973141-23-000060 001-38295 23980781 33 5149
2023-05-26 SC 13D/A GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 0001072613-23-000346 005-90199 23967683 34 460146
2023-05-16 8-K 8-K 1.01,3.02,7.01,8.01 0001628280-23-018424 001-38295 23927874 34 4772684 1 1
2023-05-04 10-Q 10-Q 0001628280-23-015763 001-38295 23889054 34 7256056 1 1
2023-05-04 8-K 8-K 7.01 0001628280-23-015714 001-38295 23888688 34 177769 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001628280-23-015494 001-38295 23886795 34 298856 1 1
2023-05-04 8-K 8-K 2.01,9.01 0001628280-23-015415 001-38295 23886314 34 298828 1 1
2023-04-27 DEFA14A DEFA14A 0001628280-23-013590 001-38295 23857364 34 16493
2023-04-25 ARS ARS 0001628280-23-012964 001-38295 23845378 34 1808830
2023-04-25 DEFA14A DEFA14A 0001628280-23-012944 001-38295 23845185 34 437865
2023-04-25 DEF 14A DEF 14A 0001628280-23-012932 001-38295 23844974 34 1285884
2023-03-21 8-K 8-K 7.01 0001628280-23-008761 001-38295 23750360 34 161423 1 1
2023-03-21 10-K 10-K 0001628280-23-008745 001-38295 23749941 34 36036716 1 1
2023-03-21 8-K 8-K 2.02 0001628280-23-008677 001-38295 23747831 34 294465 1 1
2023-03-13 4 FORM 4 0001628280-23-007724 5353
2023-03-13 4 FORM 4 0001628280-23-007722 5323
2023-03-13 4 FORM 4 0001628280-23-007721 5399
2023-03-13 4 FORM 4 0001628280-23-007720 5393
2023-03-10 8-K 8-K 8.01 0001628280-23-007516 001-38295 23723596 34 178158 1 1
2023-02-15 4 FORM 4 0001628280-23-003759 5398
2023-02-15 4 FORM 4 0001628280-23-003758 5353
2023-02-15 4 FORM 4 0001628280-23-003757 5314
2023-02-15 4 FORM 4 0001628280-23-003755 5402
2023-02-14 SC 13G/A AMENDMENT NO. 3 0000947871-23-000194 005-90199 23631855 34 72483
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-23-000393 005-90199 23629627 34 44402
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-037932 005-90199 23624760 34 68118
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-037002 005-90199 23622087 34 140712
2023-02-14 SC 13G/A AMENDMENT NO. 4 TO THE SCHEDULE 13G 0000921895-23-000465 005-90199 23620468 34 280468
2023-01-20 S-8 S-8 0001628280-23-001353 333-269335 23541540 33 133201
2023-01-13 SC 13G X4 PHARMACEUTICALS, INC. 0000902664-23-000237 005-90199 23527305 34 84036
2023-01-06 8-K 8-K 1.01,2.03 0001628280-23-000666 001-38295 23516023 34 186737 1 1
2023-01-05 8-K 8-K 7.01 0001628280-23-000455 001-38295 23511378 34 177710 1 1
2022-12-23 8-K 8-K 5.02,9.01 0001193125-22-311765 001-38295 221485332 34 228062 1 1
2022-12-20 SC 13D/A GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 0001072613-22-000662 005-90199 221472199 34 510893
2022-12-09 8-K 8-K 1.01,8.01 0001628280-22-031632 001-38295 221453722 34 980663 1 1
2022-12-09 424B5 424B5 0001193125-22-301149 333-249544 221453320 33 659955
2022-12-07 424B5 424B5 0001193125-22-299607 333-249544 221449022 33 662105
2022-11-29 8-K 8-K 7.01,8.01 0001628280-22-030943 001-38295 221432814 34 2753705 1 1
2022-11-09 4 FORM 4 0001628280-22-029265 5603
2022-11-09 4 FORM 4 0001628280-22-029261 5617
2022-11-09 4 FORM 4 0001628280-22-029260 5650
2022-11-09 4 FORM 4 0001628280-22-029259 5642
2022-11-09 8-K 8-K 5.02 0001628280-22-029252 001-38295 221372910 34 275117 1 1
2022-11-04 4 FORM 4 0001628280-22-028462 5592
2022-11-04 3 FORM 3 0001628280-22-028460 6944
2022-11-03 10-Q 10-Q 0001628280-22-028201 001-38295 221358190 34 7424500 1 1
2022-11-03 8-K 8-K 2.02,8.01 0001628280-22-027967 001-38295 221356211 34 326171 1 1
2022-10-04 8-K 8-K 7.01,8.01 0001628280-22-025971 001-38295 221292413 34 311602 1 1
2022-09-27 8-K 8-K 7.01,8.01 0001628280-22-025519 001-38295 221267281 34 4557393 1 1
2022-09-01 8-K 8-K 3.03,5.03,5.07 0001628280-22-024161 001-38295 221221513 34 3062911 1 1
2022-08-19 4 FORM 4 0001628280-22-023326 5302
2022-08-19 4 FORM 4 0001628280-22-023325 5326
2022-08-19 4 FORM 4 0001628280-22-023324 5547
2022-08-19 4 FORM 4 0001628280-22-023323 5300
2022-08-11 DEF 14A DEF 14A 0001193125-22-218580 001-38295 221156229 34 456702
2022-08-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-08-05 16:00:00 9999999995-22-002280 333-266410 221142391 33 1823
2022-08-05 424B3 424B3 0001193125-22-213712 333-266410 221141629 33 189453
2022-08-05 8-K 8-K 7.01 0001628280-22-021240 001-38295 221138673 34 4295619 1 1
2022-08-04 10-Q 10-Q 0001628280-22-021070 001-38295 221136648 34 6702611 1 1
2022-08-04 8-K 8-K 2.02 0001628280-22-020859 001-38295 221134693 34 303578 1 1
2022-08-03 CORRESP filename1.htm 0001193125-22-210648 8234
2022-08-02 UPLOAD filename1.pdf 0000000000-22-008144 40273
2022-08-01 PRE 14A PRE 14A 0001193125-22-208632 001-38295 221124702 34 456863
2022-07-29 S-3 S-3 0001193125-22-206657 333-266410 221121088 33 292708
2022-07-29 8-K 8-K 5.02 0001193125-22-206598 001-38295 221120774 34 146140 1 1
2022-07-29 424B3 424B3 0001628280-22-019770 333-264459 221117368 33 113667
2022-07-19 SC 13D GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 0001072613-22-000489 005-90199 221092304 34 510110
2022-07-19 D xslFormDX01/primary_doc.xml 06b 0001231919-22-000047 021-452949 221091760 33 17797
2022-07-01 4 FORM 4 0001628280-22-018400 5297
2022-07-01 4 FORM 4 0001628280-22-018397 5324
2022-07-01 8-K 8-K 1.01,2.03,3.02,8.01 0001628280-22-018392 001-38295 221061952 34 1090960 1 1
2022-06-27 4 FORM 4 0001628280-22-018055 5075
2022-06-27 4 FORM 4 0001628280-22-018054 5133
2022-06-27 4 FORM 4 0001628280-22-018052 5062
2022-06-27 4 FORM 4 0001628280-22-018051 5056
2022-06-27 4 FORM 4 0001628280-22-018050 5078
2022-06-27 4 FORM 4 0001628280-22-018048 5067
2022-06-27 4 FORM 4 0001628280-22-018047 5297
2022-06-27 4 FORM 4 0001628280-22-018045 5024
2022-06-27 4 FORM 4 0001628280-22-018044 5500
2022-06-27 4 FORM 4 0001628280-22-018043 5544
2022-06-27 4 FORM 4 0001628280-22-018042 5300
2022-06-17 4 FORM 4 0001628280-22-017438 5297
2022-06-17 4 FORM 4 0001628280-22-017436 5363
2022-06-17 4 FORM 4 0001628280-22-017435 5322
2022-06-17 4 FORM 4 0001628280-22-017433 5300
2022-06-07 8-K 8-K 5.07 0001628280-22-016443 001-38295 221001210 34 190038 1 1
2022-06-06 4 FORM 4 0001628280-22-016336 5583
2022-05-20 8-K 8-K 7.01,8.01 0001628280-22-015040 001-38295 22947721 34 183489 1 1
2022-05-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-13 16:00:00 9999999995-22-001472 333-264459 22925138 33 1822
2022-05-12 10-Q 10-Q 0001628280-22-014095 001-38295 22918219 34 6473358 1 1
2022-05-12 CORRESP filename1.htm 0001193125-22-148609 7884
2022-05-12 8-K 8-K 2.02,7.01 0001628280-22-013956 001-38295 22915766 34 285237 1 1
2022-04-28 UPLOAD filename1.pdf 0000000000-22-004554 40300
2022-04-25 DEFA14A DEFA14A 0001628280-22-010147 001-38295 22850580 34 473129
2022-04-25 DEF 14A DEF 14A 0001628280-22-010145 001-38295 22850574 34 945719
2022-04-22 S-3 S-3 0001628280-22-010034 333-264459 22846681 33 287104
2022-03-22 424B5 424B5 0001628280-22-006888 333-242372 22759643 33 54413
2022-03-17 10-K 10-K 0001628280-22-006547 001-38295 22748688 34 11055845 1 1
2022-03-17 8-K 8-K 2.02,7.01 0001628280-22-006482 001-38295 22746850 34 312238 1 1
2022-03-10 S-8 S-8 0001628280-22-005734 333-263430 22729634 33 132096

Latest XBRL company facts

One latest value per concept from companyfacts (398 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 102.11M 2026-11-02 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
dei EntityPublicFloat Entity Public Float USD 14.90M 2025-06-30 2025 FY 10-K 2026-03-17 0001501697-26-000018
ffd NetFeeAmt NetFeeAmt USD 25,922.79 2026-05-06 S-3 2026-05-06 0001501697-26-000043
ffd TtlFeeAmt TtlFeeAmt USD 25,922.79 2026-05-06 S-3 2026-05-06 0001501697-26-000043
ffd TtlOfferingAmt TtlOfferingAmt USD 300.00M 2026-05-06 S-3 2026-05-06 0001501697-26-000043
us-gaap AcceleratedShareRepurchasesInitialPricePaidPerShare Accelerated Share Repurchases, Initial Price Paid Per Share USD/shares 2.17 2022-01-14 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 984,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 3.09M 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 110,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 789.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AdjustmentForAmortization Amortization USD 289,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001628280-25-021358
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 817,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.50M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 3.50M 2021-04-01 2021-06-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021795
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 9.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 600,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001501697-25-000043
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 18.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AssetAcquisitionConsiderationTransferredOtherAssets AssetAcquisitionConsiderationTransferredOtherAssets USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap Assets Assets USD 231.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AssetsCurrent Assets, Current USD 198.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 159.79M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 2.44M 2019-03-13 2019 Q3 10-Q 2019-11-07 0001628280-19-013715
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 0.64 2019-03-13 2020 FY 10-K 2021-03-19 0001628280-21-005202
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -57.82M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 1.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 205,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CapitalizedContractCostAmortization Capitalized Contract Cost, Amortization USD 3.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CapitalizedContractCostGross Capitalized Contract Cost, Gross USD 4.00M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CapitalizedContractCostNet Capitalized Contract Cost, Net USD 700,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CapitalizedContractCostNetCurrent Capitalized Contract Cost, Net, Current USD 200,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CapitalizedContractCostNetNoncurrent Capitalized Contract Cost, Net, Noncurrent USD 500,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 185.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 123.84M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 187.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 186.48M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -31.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.03 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 15.24M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 37.92M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 2.73M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 100.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 100.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CommonStockValue Common Stock, Value, Issued USD 101,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -37.45M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 1.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price USD 401,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 938,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 391,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -157,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ConvertibleDebt Convertible Debt USD 0 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap CostOfRevenue Cost of Revenue USD 2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap CostsAndExpenses Costs and Expenses USD 38.96M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 28,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 13,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 9.74M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 2.10M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 317,000 2019-12-31 2020 FY 10-K 2021-03-19 0001628280-21-005202
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 19,000 2017-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 1.84M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap DebtInstrumentUnamortizedDiscountPremiumNet Debt Instrument, Unamortized Discount (Premium), Net USD 215,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap DebtInstrumentUnamortizedPremium Debt Instrument, Unamortized Premium USD 223,000 2020-12-31 2020 FY 10-K 2021-03-19 0001628280-21-005202
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 399,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 3.50M 2021-03-23 2021 Q3 10-Q 2021-11-04 0001628280-21-021795
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 93,000 2018-12-31 2019 Q1 10-Q 2019-05-15 0001193125-19-148119
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 417,000 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 214.58M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 399,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 129.94M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.58M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 25.16M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Deferred Tax Assets, Tax Credit Carryforwards, General Business USD 7.75M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 18.65M 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.46M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 214.19M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap Depreciation Depreciation USD 125,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 288,000 2021-03-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 948,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap DerivativeLiabilities Derivative Liability USD 10,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 29,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap DividendsPaidinkind Dividends, Paid-in-kind USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001628280-23-038334
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.31 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-021070
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.296 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.002 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.032 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.58M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 18.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.75 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -4.60M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001628280-24-047445
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012719
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -948,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 41.25M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028201
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 374,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001628280-23-038334
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 39,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 288,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-07 0001628280-20-006998
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 33.66M 2021-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 795,000 2021-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 7.01M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 277,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 15.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 12.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 105.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001628280-24-047445
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 500,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001628280-23-038334
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-21 0001628280-23-008745
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD 105.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001628280-24-047445
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 24.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap Goodwill Goodwill USD 17.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 0 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap GoodwillGross Goodwill, Gross USD 27.11M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 9.76M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 298,000 2019-04-01 2019-06-30 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -79.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -56.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 251,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -61.98M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-19 0001628280-21-005202
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 338,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 210,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 23.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -16.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 548,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 52,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 10,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -815,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 897,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -9.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 243,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 4.90M 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-029551
us-gaap InterestExpense Interest Expense USD 6.46M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001628280-24-047445
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 6.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 8.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 256,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 680,000 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap InventoryGross Inventory, Gross USD 5.51M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap InventoryNet Inventory, Net USD 2.82M 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 1.53M 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 3.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 608,000 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.30M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap LeaseCost Lease, Cost USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 191,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.05M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015792
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.05M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 47,000 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 45,000 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 51,000 2025-06-30 2025 Q2 10-Q 2025-08-08 0001628280-25-039327
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 306,000 2025-06-30 2025 Q2 10-Q 2025-08-08 0001628280-25-039327
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 765,000 2026-03-31 2026 Q1 10-Q 2026-05-06 0001501697-26-000040
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap Liabilities Liabilities USD 92.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 231.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 403,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap LiabilitiesCurrent Liabilities, Current USD 14.98M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 987,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap LoansPayable Loans Payable USD 7.89M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap LoansPayableCurrent Loans Payable, Current USD 2.31M 2017-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap LongTermDebt Long-term Debt USD 75.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities Long-term Debt and Lease Obligation, Including Current Maturities USD 54.32M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001628280-23-038334
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 8.10M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001628280-19-013715
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 11.31M 2020-12-31 2020 FY 10-K 2021-03-19 0001628280-21-005202
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 76.08M 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 76.70M 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001501697-25-000043
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 54.57M 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 7.89M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap MarketableSecurities Marketable Securities USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 4,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -626,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012719
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 29.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -17,000 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012719
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -60.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -12.18M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012719
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -56.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -37.45M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 2,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 60,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 97,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap NumberOfReportingUnits Number of Reporting Units reporting_unit 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap OperatingExpenses Operating Expenses USD 37.29M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0001628280-24-021120
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -56.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 189,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 189,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap OperatingLeasePayments Operating Lease, Payments USD 861,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 264,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.96M 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 884,000 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 263,000 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 492,000 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 835,000 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 823,000 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 263,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028766
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 810,000 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.115 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherAssetsCurrent Other Assets, Current USD 338,000 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012719
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -119,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 119,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD -119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD -42,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-029551
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -56.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 522,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 69,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -264,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 359,000 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap PaymentsForRepurchaseOfConvertiblePreferredStock Payments for Repurchase of Convertible Preferred Stock USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-19 0001628280-21-005202
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PaymentsForSecuritiesPurchasedUnderAgreementsToResell Payments for Securities Purchased under Agreements to Resell USD 3.00M 2022-01-14 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 112,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 30,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 43,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028766
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015792
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 7.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 326,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PrepaidInsurance Prepaid Insurance USD 1.01M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-19 0001628280-21-005202
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 46.00M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 694,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021795
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 20.00M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 40.05M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 20.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001628280-24-047445
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 58.10M 2017-11-19 2017-11-20 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 34.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 105.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap ProceedsFromSalesOfAssetsInvestingActivities Proceeds from Sales of Assets, Investing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 113,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001193125-19-148119
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 76,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -37.45M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.44M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap PurchaseObligation Purchase Obligation USD 1.90M 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 38.75M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001628280-24-047445
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 43.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RestrictedCash Restricted Cash USD 675,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 580,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 95,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 0 2024-04-01 2024-06-30 2024 Q3 10-Q 2024-11-13 0001628280-24-047445
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 28 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent pure 0.65 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.65 2018-08-10 2019-03-01 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap RestructuringCharges Restructuring Charges USD 235,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RestructuringReserve Restructuring Reserve USD 73,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -651.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 14.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap Revenues Revenues USD 7.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap RoyaltyExpense Royalty Expense USD 100,000 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0001628280-25-039327
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 1.8 2021-03-23 2022 Q1 10-Q 2022-05-12 0001628280-22-014095
us-gaap SeveranceCosts1 Severance Costs USD 1.65M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 9.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 269 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 431,923 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028201
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 4.69M 2023-01-01 2023-03-31 2022 Q3 10-Q 2023-05-04 0001628280-23-015763
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 5.84M 2023-03-31 2022 Q3 10-Q 2023-05-04 0001628280-23-015763
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 5.51 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 540,238 2023-01-01 2023-03-31 2022 Q3 10-Q 2023-05-04 0001628280-23-015763
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share USD/shares 4.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 1.64 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0001628280-25-039327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.038 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0001628280-25-039327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0001628280-25-039327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 10.41M 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 6.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.48 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 11.77 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028766
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 889,909 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 18.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 12.35 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 15.55M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 15.92M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.5 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 1.05M 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 2.53 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 13.85M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 14.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.50M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.5 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 7.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap SharesOutstanding Shares, Outstanding shares 16.29M 2020-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021795
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 138.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.033 2025-04-28 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 7.18M 2017-11-19 2017-11-20 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 257,963 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 1,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001628280-21-009166
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 900,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001628280-22-014095
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 132,537 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-21 0001628280-23-008745
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2,031 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 45.54M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 64.67M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 76,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 297,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 86.68M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 2,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001628280-25-014805
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 40,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 229,885 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap SubleaseIncome Sublease Income USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015792
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 1.88M 2021-06-30 2021 Q2 10-Q 2021-08-03 0001628280-21-015330
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 84.07M 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 49.41M 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 40.08M 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 40.08M 2018-12-31 2019 FY 10-K 2020-03-12 0001628280-20-003484
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 200,000 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition USD 100,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-21 0001628280-24-012578
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 94,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-11 0001564590-19-007097
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD -100,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001628280-22-006547
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 29.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001501697-26-000018
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount USD 2.55M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028201
us-gaap WeightedAverageDiscountRatePercent Weighted Average Discount Rate, Percent (Deprecated 2019-01-31) pure 0.195 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-029551
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001501697-26-000040
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 126.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 34.59M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-021070
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 126.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001501697-26-000089

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →